marijuana stocks news

PotNetwork Holding, Inc. Continues to Strengthen Advisory Board with the Appointment of Distinguished Medical Marijuana Certified Physician

PotNetwork Holding, Inc. (OTC Pink: POTN) today announces that as part of its strategy to formulate, produce and market a spectrum of exclusive and diversely targeted cannabidiol blends, the Company has appointed Dr. Michael McKenzie, industry leading physician, to the Company’s advisory board to empower management with valuable guidance, resources and insight as the Company mobilizes to serve the growing demand for premium medicinal grade products.

Dr. Michael McKenzie, practitioner in family medicine, has positioned himself at the forefront of the industry by gaining a keen understanding of cannabis and its impact on a number of illnesses. In addition to providing medical cannabis certifications in South Florida to qualifying patients, offering compassionate care and excellent bedside manner, Dr. McKenzie takes pride in being able to help his patients achieve an improved quality of life.

Having completed his doctorate from the Universidad Iberoamericana, Dr. Michael McKenzie has been practicing medicine for nearly twenty years. Certified in family medicine, he was determined to include medical marijuana certifications as a part of his practice after witnessing its anecdotal successes treating a variety of health concerns and supplementing his thorough research. Dr. Michael McKenzie is a medical marijuana doctor that genuinely believes that medical cannabis is a revolutionary and highly effective component in helping patients achieve lasting health and wellness.

“Dr. McKenzie is going to be an invaluable addition to our team. He has already been very instrumental in providing valuable guidance, and has proved to be a knowledgeable and influential contributor. We are very pleased with his addition to our team,” states PotNetwork Holding Chief Executive Officer Dr. Richard Goulding. In the Company’s effort to fortify its presence in the industry with a specialized focus, management has resolved to enhance the Board of Advisors with industry pioneers who can be instrumental in directing the Company’s endeavors to develop targeted formulas designed to deliver results for a diverse spectrum of challenges that studies reveal CBD can help.

Diamond CBD has focused determination to assemble a team of medical professionals with an acquired knowledge of the intricacies and attributes of CBD and how these components can contribute to the optimization of beneficial results. “This enhancement to our management team is a strategic move to enhance the Company’s capability to contend in a sector of the marketplace focused on the beneficial uses of CBD,” stated Maria Gomez, Regional Vice President of Sales of Diamond CBD, Inc.

PotNetwork has recently formed an advisory board created to provide its subsidiary, Diamond CBD, Inc., with guidance and insight on upcoming formulations. Broad, third party CBD research demonstrates its potential to provide symptomatic relief for a wide range of ailments, including rheumatoid arthritis, diabetes, alcoholism, post traumatic stress disorder, epilepsy, antibiotic-resistant infections, neurological disorders, and muscular dystrophy, among numerous reportedly wide-scale healing properties and relieving benefits. Diamond CBD is focused on continuing this research to develop premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives to address these key markets.

Diamond CBD maintains pride and intensity in bringing top quality hemp-derived products to market. While these consumables are sold as dietary supplements, the Company makes no claim on the potential effects that their proprietary products will have on anyone’s individual illness or symptoms.

About Diamond CBD, Inc.: Diamond CBD focuses on the research, development, and multi-national marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. Diamond CBD’s team consists of hemp industry pioneers and natural product experts, chemists, doctors and scientists, dedicated to producing the finest and purest cannabidiol (CBD) oils. The result is a robust selection considered among the most powerful natural CBD oils, tinctures, edibles, and vape liquids found anywhere. For more information, please visit its website at

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$INSY Reports Second Quarter 2015 Results

Insys Therapeutics Reports Second Quarter 2015 Results  Insys Therapeutics, Inc. (NASDAQ: INSY)…

GrowGeneration Corp. (GRWG) Schedules Second Quarter 2022 Earnings Release and Conference Call for August 4, 2022

GrowGeneration Schedules Second Quarter 2022 Earnings Release and Conference Call for August…

Digipath, Inc. (DIGP) Receives Recreational Testing License and Renews Medical License

Digipath Receives Recreational Testing License and Renews Medical License as Retail Cannabis…

Lexaria Bioscience Corp. (LXRP) (LXX.CN) Announces it has Received Four New Patents

Lexaria Bioscience Announces it has Received Four New Patents Lexaria Bioscience Corp.…